Literature DB >> 18487573

Histologic results of para-aortic lymphadenectomy in patients treated for stage IB2/II cervical cancer with negative [18F]fluorodeoxyglucose positron emission tomography scans in the para-aortic area.

Mathias Boughanim1, Sophie Leboulleux, Annie Rey, Chi Tuan Pham, Yaelle Zafrani, Pierre Duvillard, Jean Lumbroso, Christine Haie-Meder, Martin Schlumberger, Philippe Morice.   

Abstract

PURPOSE: Histologic results of complete para-aortic lymphadenectomy were studied in patients treated for stage IB2/II cervical carcinoma who had no para-aortic uptake on [(18)F]fluorodeoxyglucose positron emission tomography combined with integrated computed tomography (FDG-PET/CT). PATIENTS AND METHODS: Patients were treated between 2004 and 2006 for stage IB2/II cervical cancer. Magnetic resonance imaging of the abdomen and pelvis and FDG-PET/CT were initially performed. Patients with no para-aortic abnormalities were treated with external pelvic radiation therapy and concomitant chemotherapy followed by utero-vaginal brachytherapy. Para-aortic lymphadenectomy was then performed. FDG-PET/CT images were reviewed by two nuclear medicine specialists.
RESULTS: Thirty-eight patients were studied. Three patients had histologically proven para-aortic involvement (metastatic nodes with capsular rupture in the para-aortic area), leading to a negative predictive value of 92% for para-aortic nodal involvement.
CONCLUSION: In this study, three of 38 patients with no para-aortic uptake on [(18)F]FDG-PET/CT imaging had histologically proven para-aortic node involvement. PET/CT imaging without histologic examination of the para-aortic area used to determine radiation therapy fields in stage IB2/II cervical cancer would overlook 8% of patients with histologic para-aortic nodal involvement.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18487573     DOI: 10.1200/JCO.2007.14.3933

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN: 0732-183X            Impact factor:   44.544


  11 in total

Review 1.  Chemoradiotherapy for cervical cancer in 2010.

Authors:  Ann H Klopp; Patricia J Eifel
Journal:  Curr Oncol Rep       Date:  2011-02       Impact factor: 5.075

Review 2.  FDG-PET in gynaecological cancers: recent observations.

Authors:  Giovanni Lucignani
Journal:  Eur J Nucl Med Mol Imaging       Date:  2008-11       Impact factor: 9.236

Review 3.  Analysis of morbidity and clinical implications of laparoscopic para-aortic lymphadenectomy in a continuous series of 98 patients with advanced-stage cervical cancer and negative PET-CT imaging in the para-aortic area.

Authors:  Catherine Uzan; Amine Souadka; Sebastien Gouy; Thierry Debaere; Juliette Duclos; Jean Lumbroso; Christine Haie-Meder; Philippe Morice
Journal:  Oncologist       Date:  2011-06-09

Review 4.  Does para-aortic irradiation reduce the risk of distant metastasis in advanced cervical cancer? A systematic review and meta-analysis of randomized clinical trials.

Authors:  Lucas Gomes Sapienza; Maria José Leite Gomes; Vinicius Fernando Calsavara; Mario M Leitao; Glauco Baiocchi
Journal:  Gynecol Oncol       Date:  2016-11-28       Impact factor: 5.482

5.  Prognostic factors and morbidities after completion surgery in patients undergoing initial chemoradiation therapy for locally advanced cervical cancer.

Authors:  Cyril Touboul; Catherine Uzan; Audrey Mauguen; Sebastien Gouy; Annie Rey; Patricia Pautier; Catherine Lhommé; Pierre Duvillard; Christine Haie-Meder; Philippe Morice
Journal:  Oncologist       Date:  2010-03-23

6.  Results of the GYNECO 02 study, an FNCLCC phase III trial comparing hysterectomy with no hysterectomy in patients with a (clinical and radiological) complete response after chemoradiation therapy for stage IB2 or II cervical cancer.

Authors:  Philippe Morice; Philippe Rouanet; Annie Rey; Pascale Romestaing; Gilles Houvenaeghel; Jean Charles Boulanger; Jean Leveque; Didier Cowen; Patrice Mathevet; Jean Pierre Malhaire; Guillaume Magnin; Eric Fondrinier; Jocelyne Berille; Christine Haie-Meder
Journal:  Oncologist       Date:  2012-01-10

7.  The role of PET/CT in cervical cancer.

Authors:  Fernanda G Herrera; John O Prior
Journal:  Front Oncol       Date:  2013-02-26       Impact factor: 6.244

Review 8.  The role of PET-CT in radiotherapy planning of solid tumours.

Authors:  Stasa Jelercic; Mirjana Rajer
Journal:  Radiol Oncol       Date:  2015-03-03       Impact factor: 2.991

9.  Fluorodeoxyglucose positron emission tomography-computed tomography in evaluation of pelvic and para-aortic nodal involvement in early stage and operable cervical cancer: Comparison with surgicopathological findings.

Authors:  Vandana Bansal; Kaizad Damania; Anshu Rajnish Sharma
Journal:  Indian J Nucl Med       Date:  2011-10

10.  Predictive factors of para-aortic lymph nodes metastasis in cervical cancer patients: a retrospective analysis based on 723 para-aortic lymphadenectomy cases.

Authors:  Xiaotian Han; Hao Wen; Xingzhu Ju; Xiaojun Chen; Guihao Ke; Yuqi Zhou; Jin Li; Lingfang Xia; Jia Tang; Shanhui Liang; Xiaohua Wu
Journal:  Oncotarget       Date:  2017-03-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.